Published a correction to the use of procured funds and timing of expenditures. Corrects the specific uses and amounts related to the 9th stock acquisition rights, unsecured straight bonds, and loans\/investments\/repayments related to Kaihan Medical.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"3133","jir_company_name":"kaihan co.,Ltd.","jir_importance":"\u2605\u2605\u2605\u2606\u2606","jir_publication_date":"2026-11-13","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/11\/3133-20261113-04.pdf","jir_short_summary":"Published a correction to the use of procured funds and timing of expenditures. Corrects the specific uses and amounts related to the 9th stock acquisition rights, unsecured straight bonds, and loans\/investments\/repayments related to Kaihan Medical.","jir_summary":"### Overview of the Correction\nToday, we are issuing a correction to the \"Notice of Changes to Use of Procured Funds and Timing of Expenditures\" originally disclosed on May 19, 2026, because there were errors in the recorded actual allocations and uses. In particular, we have corrected the recorded allocation amounts, timing of expenditures for unsecured straight bonds and stock acquisition rights, and omissions regarding loan repayment recipients. The corrected specific uses include working capital for the food and beverage business; investments, loans related to solar and hydropower generation equipment; loans to Kaihan Medical; and repayment of borrowings related to M&A, among others.\n\n### Impact and Future Outlook\nThis correction is not expected to affect the consolidated financial results for the fiscal year ending March 2027, and its impact on financial calculations and capital structure is expected to be limited. The corrections are limited to revisions of amounts and timing of expenditures, and the overall direction of the funding plan is expected to be maintained.","jir_financial_highlights":"Total: 1,497 (Conceptual allocation and actual amounts improved\/changed before and after correction)","jir_category":"","jir_hashtags":"#kaihan, Correction with additional specific disclosures, Not related to share buybacks or executive personnel changes","jir_key_figures":"Total: 1,497 million yen\nLoan to Kaihan Medical: 3 million yen\nAdjustment of loan timing due to payment timing for Kaihan Medical's new store opening: February 2026","jir_meta_title":"kaihan co.,Ltd. \u2014 Correction Notice: Revised Use and Timing of Procured Funds","jir_meta_description":"kaihan co.,Ltd. announces a correction to the use and timing of procured funds, revising specific uses and amounts related to the 9th stock acquisition rights, unsecured bonds, and Kaihan Medical. No impact on FY2027 consolidated results is expected.","jir_og_title":"kaihan co.,Ltd. Correction Notice: Revised Use of Funds","jir_og_description":"Announces correction to the use and timing of procured funds, revising amounts related to stock acquisition rights, bonds, and Kaihan Medical. No impact expected on FY2027.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":57441,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"disclosure_update","footnotes":""},"sector":[],"importance":[],"class_list":["post-153005","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n